1. P152 Fluticasone furoate (FF)/Vilanterol (VI) once daily reduces asthma symptoms both day and night. (12th November 2015) Authors: Leather, DA; Forth, R; Yates, L; Jacques, LA Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P42 Deprivation is associated with higher healthcare use in the salford lung study in asthma (SLS asthma). (December 2018) Authors: Collier, S; Jones, R; Lay-Flurrie, J; Svedsater, H; Jacques, L; Bakerly, ND; Woodcock, A; Vestbo, J; Leather, DA Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P155 Fluticasone furoate (FF)/Vilanterol (VI) once daily reduces rescue medication use both day and night. (12th November 2015) Authors: Jacques, LA; Forth, R; Yates, L; Leather, DA Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P26 How does the salford lung study in copd (sls copd) patient population fit into the gold 2017 classification grid?. (15th November 2017) Authors: Vestbo, J; Boucot, I; Frith, L; Bakerly, N Diar; Collier, S; Leather, DA; Gibson, JM; Woodcock, A Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗